SERUM LEVEL OF VCAM-1, ICAM-1, E-SELECTIN IN TYPE 2 DIABETES AND OBESETY

Authors

  • Mogylnytska L. A. Khmelnytsky regional hospital, Khmelnytsky

DOI:

https://doi.org/10.21856/j-PEP.2015.3.06

Keywords:

VEGF, type 2 diabetes, obesity, endothelial dysfunction

Abstract

The study revealed an elevation of serum levels of VCAM-1, ICAM-1, E-selectin in obese and nonobese type 2 diabetes patients and obese subjects without diabetes. An elevation of serum levels of VCAM-1, ICAM-1, E-selectin is associated with hyperglycemia and dyslipidemia in non-obese type 2 diabetes patients. An increase of VCAM-1, ICAM-1, E-selectin is associated with body mass index, an markers of insulin resistance and lipid metabolism in obese type 2 diabetes patients and obese subjects without diabetes. Detect changes point to the development of endothelial dysfunction in patients with type 2 diabetes with different body weight and obese subjects without diabetes.

References

Basha B, Samuel SM, Triggle CR, et al. Exp Diabetes Res 2012; 2012:481840.

Jansson PA. J Intern Med 2007; 262(2):173-183.

Uğurlu N, Gerceker S, Yülek F, et al. Intern Med 2013; 52(19):2173-2178.

Nakashima Y, Raines EW, Plump AS, et al. Arterioscler Thromb Vasc Biol 1998; 18:842-851.

Blankenberg S, Barbaux S, Tiret L. Atherosclerosis 2003; 170:191-203.

Binder FP, Ernst B. Chimia (Aarau) 2011; 65(4):210-213.

Empen K, Frost RJ, Geiss HC, et al. Cardiovasc Diabetol 2003; 2:17.

Mizia-Stec K, Gąsior Z, Zahorska-Markiewicz B, et al. Diabetologia Doświadczalna i Kliniczna 2003; 3(6):523-529.

Thorand B, Baumert J, Chambless L, et al. Arterioscler Thromb Vasc Biol 2006; 26(2):398-405.

Hadi AR, Suwaidi J. Vasc Health Risk Manag 2007; 3(6):853-876.

Ruszkowska-Ciastek B, Sokup A, Wernik T, et al. J Zhejiang Univ Sci B 2015; 16(5):355-361.

Liu JJ, Yeoh LY, Sum CF, et al. J Diabetes Complications 2015; 29(5):707-712.

Joy NG, Tate DB, Younk LM, Davis SN. Diabetes 2015; 18:141729.

Sozer V, Himmetoglu S, Korkmaz GG, et al. Minerva Med 2014; 105(3):237-244.

Mogensen CE, Christensen CK, Vittinghus E. Diabetes 1983; 32(2):64-78.

Tangvarasittichai S. World J Diabetes 2015; 6(3):456-480.

Bornfeldt KE, Tabas I. Cell Metab 2011; 14(5):575-585.

Pansuria M, Xi H, Li L, et al. Front Biosci (Schol Ed) 2012; 4:916-931.

Downloads

Published

2021-08-17

How to Cite

Mogylnytska, L. A. (2021). SERUM LEVEL OF VCAM-1, ICAM-1, E-SELECTIN IN TYPE 2 DIABETES AND OBESETY. Problems of Endocrine Pathology, 53(3), 45-52. https://doi.org/10.21856/j-PEP.2015.3.06

Issue

Section

CLINICAL ENDOCRINOLOGY